ACE2 and infection: According to preclinical evidence, SARS-CoV-2 activates the acid sphingomyelinase/ceramide system, resulting in the formation of ceramide-enriched membrane domains that may facilitate viral entry and infection by clustering ACE2, the cellular receptor of SARS-CoV-2 (29,48).